Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 02 Mar 2026 for Ovid Therapeutics Inc., €10k.
Filing timeline
BuySaleJeffrey A. Rona
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Jeffrey A. Rona: trading record in brief
Jeffrey A. Rona discloses dealings in 2 companies, chiefly Ovid Therapeutics Inc. and S&W Seed Co. Between 15 December 2023 and 26 February 2026, the trades on record add up to 7 filings.
Every open-market trade on record is a sale: 2 sales worth €13k. Other entries cover 5 share grants. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 2 March 2026: a share grant, in Ovid Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey A. Rona
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
8,541 shares@ US$1.4583.4% of flowCommon StockSEC:0001311404-26-000002:0
3,902 shares@ US$0.5616.6% of flowCommon StockSEC:0001415889-25-005997:0
43,750 shares0Common StockSEC:0001415889-25-005367:0
12,725 shares0Common StockSEC:0001415889-24-029863:0
28,125 shares0Common StockSEC:0001209191-24-003970:0
151,525 shares0Common StockSEC:0001209191-23-059219:0
6 of 6 declarations
